Tim Lowinger

Tim Lowinger

Company: Mersana

Job title: Chief Scientific Officer


A Clinical Update on UpRi (Upifitimab Rilsodotin) 4:30 pm

Clinical Results from the Phase I Dose Expansion Study of UpRi Population PK-Based Dose Refinement Optimization of the Companion Diagnostic Assay to Enrich for Likelihood of Clinical ResponseRead more

day: day 2 opps
day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.